PLPing Li

Ping Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ping Li has a total of 119 co-authors. Here are the top co-authors by number of shared publications:

  • Tingting Di

    Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Institute of Traditional Chinese Medicine, Beijing Key Laboratory of Clinic and Basic Research with Traditional Chinese Medicine on Psoriasis, Beijing 100010, China

    9 shared publications
  • Yan Wang

    Beijing Hospital Beijing Institute of Traditional Chinese Medicine Traditional Chinese Medicine Affiliated to Capital Medical University 100010 Beijing China

    9 shared publications
  • Yujiao Meng

    Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Institute of Chinese Medicine, Beijing Key Laboratory of Clinic and Basic Research with Traditional Chinese Medicine on Psoriasis, Beijing, People’s Republic of China

    9 shared publications
  • Jingxia Zhao

    8 shared publications
  • Lu Zhang

    Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Institute of Traditional Chinese Medicine, Beijing Key Laboratory of Clinic and Basic Research with Traditional Chinese Medicine on Psoriasis, Beijing 100010, China

    6 shared publications
  • Yan Lin

    Beijing Institute of Traditional Chinese Medicine, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China

    6 shared publications

Latest Publications

  • Open Access

    Brain-organ axis: How does stress regulate peripheral immunity through neural signaling?

    by Xiaohan Yu, Haoyue Zhu, Yanqi Su, Lijiaming Zhou, Zhenzhi Chen, Ping Li, Yan Wang


  • Open Access

    A Novel Chronic Psoriasis Mouse Model via Optimized Imiquimod Dosing and Machine Learning Evaluation

    by Haoyue Zhu, Xiaohan Yu, Yazhuo Wang, Ning Zhao, Baoquan Qu, Huike Ma, Yujiao Meng, Jingxia Zhao, Yan Wang, Ping Li

    Scope: Imiquimod (IMQ)-induced psoriasis-like mouse models are widely used for psoriasis research, but existing methods fail to sustain disease manifestation over time. This study explores the effect of different IMQ dosing frequencies on maintaining psoriasis symptoms in mice. Methods and Results: We compared a general IMQ model (General Model) with models that used spaced dosing (D-D Model) or 5– 6 doses per week (3D-D Model) over a 28-day duration. Each experimental group consisted of eight mice (n=8) to ensure statistical significance. Both the D-D and 3D-D models maintained classic pathological features of psoriasis, including immune cell accumulation in skin and sustained levels of psoriasis-related inflammatory factors in the blood, compared to the control and General Model groups. Transcriptomic analysis revealed that D-D Model and 3D-D models mice exhibited more severe psoriasis-like lesions and significantly increased expression of IL-17 and IL-23 signaling genes (IL-17A, IL-17F, S100A9) compared to the General Model. Furthermore, adjusted dosing frequencies influenced the metabolic profile, with higher regulation of TRP channels and 2-oxocarboxylic acid metabolism in the skin of D-D mice. Subsequent, Identification and validation of a conserved psoriasis biomarker signature via machine learning and cross-species analysis. Conclusion: Adjusting the dosing frequency of conventional imiquimod-induced psoriasis-like mouse models to alternate-day administration (D-D) or three days on followed by one day off (3D-D) maintained long-term psoriasis symptoms. enhancing IL-17/IL-23 signaling pathways. This modification resulted in a model exhibiting biological characteristics more closely resembling those in humans, thereby providing a more clinically relevant model for chronic psoriasis. Despite these advantages, the current model has not yet fully recapitulated the complex seasonal and cyclical nature of clinical psoriasis.

  • Open Access

    Application and prospects of artificial intelligence in traditional Chinese medicine skin diagnosis

    by Li Zhao, Jingxia Zhao, Ruonan Li, Yuchen Liu, Zhaoxia Chen, Yan Wang, Yujiao Meng, Ping Li

    Inspection is the first of the four diagnoses. Skin inspection is not only an important part of the four diagnoses of Chinese medicine, but also the characteristic and essence of Chinese dermatology. The development of artificial intelligence (AI) technology provides an opportunity for the intelligent research of skin inspection in traditional Chinese medicine (TCM). This study aims to review the application status of artificial intelligence in TCM skin inspection, and summarize the research progress of various artificial intelligence technologies in skin lesion differentiation, syndrome differentiation and location differentiation, and propose future directions for AI empowerment in TCM dermatology. Based on the basic theory of Chinese medicine and skin clinical thinking of Chinese medicine, this article puts forward the prospect of AI empowerment from the aspects of macro and micro combination, point and surface combination, mind-body combination and time-space combination. This study discusses the existing problems and challenges in the intersection of AI and TCM dermatology. The intersection of AI and TCM dermatological inspection is at the developmental stage. AI has broad application prospects within TCM dermatology, but it also faces numerous challenges. While AI offers opportunities to modernize TCM dermatology, challenges such as aligning AI with TCM’s holistic principles and ensuring clinical relevance remain. Further research integrates AI with TCM skin inspection methods, the intricate connotations and applications of TCM dermatological Inspection will be fully realized, thereby providing reference for the development of artificial intelligence to help TCM dermatology diagnosis and treatment technology.

  • Exploring the therapeutic potential of Abelmoschi Corolla in psoriasis: Mechanisms of action and inflammatory pathway disruption

    by Baoquan Qu, Guanglu Li, Ning Zhao, Ruonan Li, Huike Ma, Haoyue Zhu, Ping Li, Jingxia Zhao


  • Open Access

    Immunomodulatory effects of carbon ion radiotherapy in patients with localized prostate cancer

    by Wei Hu, Yulei Pei, Renli Ning, Ping Li, Zhenshan Zhang, Zhengshan Hong, Cihang Bao, Xiaomao Guo, Yun Sun, Qing Zhang

    Purpose: Radiotherapy is one of the main local treatment modalities for prostate cancer, while immunosuppressive effect induced by radiotherapy is an important factor of radiation resistance and treatment failure. Carbon ion radiotherapy (CIRT) is a novel radiotherapy technique and the immunomodulatory effect of CIRT provides the possibility of overcoming radioresistance and improving efficacy. The aim of this study was to assess the immune response evoked by CIRT in localized prostate cancer patients. Methods: Thirty-two patients were treated by CIRT combined with or without hormone therapy and peripheral blood samples were collected before and after CIRT. Investigation of peripheral immune cell frequency, proliferation, and cytokine expression was conducted by flow cytometry, real-time quantitative PCR and ELISA. Results: There were no significant differences in the frequencies of CD3 + , CD4 + , CD8 + T cells and NK cells after CIRT. CD4/CD8 ratio increased whereas B cells decreased. All lymphocyte subsets except regulatory T cells (Tregs) displayed increased proliferation and T cells exhibited increased functionality after CIRT, characterized by modestly increased cytokine secretion of TNF. Moreover, higher frequencies of Tregs were shown. Neither monocytic myeloid-derived suppressor cells (MDSCs) nor early MDSCs changed after CIRT. TGF-β1 gene expression decreased while IL-6 showed a non-significant trend towards a decrease. Both IL-10 gene expression and plasma TGF‐β1 level were unchanged. Conclusion: CIRT demonstrates the potential to elicit immune activation in localized prostate cancer patients, based on sparing lymphocytes, increased lymphocyte proliferation, enhanced T-cell functionality, together with limited induction of immunosuppressive cells and reduced expression of immunosuppressive cytokines.


  • Combining network pharmacology, RNA-seq, and metabolomics strategies to reveal the mechanism of Cimicifugae Rhizoma - Smilax glabra Roxb herb pair for the treatment of psoriasis

    by XueQing Hu, Cong Qi, Fang Feng, Yan Wang, TingTing Di, YuJiao Meng, Yazhuo Wang, Ning Zhao, XiaWei Zhang, Ping Li, et al.


  • Open Access

    Huiyang Shengji decoction promotes wound healing in diabetic mice by activating the EGFR/PI3K/ATK pathway

    by Qingwu Liu, Jinchao Zhang, Xuyang Han, Jia Chen, Yating Zhai, Yan Lin, Huike Ma, Fang Feng, Xiujuan He, Ping Li

    Background: Common chronic wounds include diabetic ulcers, venous ulcers, and pressure ulcers. The traditional Chinese medicine Huiyang Shengji decoction (HYSJD) has been shown to promote the healing of diabetic chronic wounds, however, its pharmacological mechanism is still unclear. Purpose: This study aimed to determine the mechanism of HYSJD in promoting the healing of diabetic chronic skin ulcers. Methods: Ultra-performance liquid chromatography was combined with tandem mass spectrometry (UPLC-MS/MS) to analyze the main components of HYSJD and the absorbed components in mouse serum at 30 min after oral administration of HYSJD. db/db mouse models for chronic skin ulcers were constructed by full-thickness skin resection. Wound tissues at day 7 post wound formation were used to perform microarray analysis of growth factors and chemokine expression. GO and KEGG enrichment analysis was performed on differentially expressed proteins. ELISA assays were used to measure differential expressed cytokines in the serum and Western blot analysis was used to determine the expression levels of related pathway proteins in the skin wounds. Results: UPLC-MS/MS analysis showed that the main chemical components of HYSJD were flavonoids, terpenes, alkaloids, phenylpropanoids, and carbohydrates. At 30 min after oral administration of HYSJD, five absorbed components were detected in the serum, these included formononetin, calycosin, hypaconitine, calycosin-7-glucoside, and sinapic acid. HYSJD was found to increase the wound healing rate in chronic skin ulcers in db/db mice at days 3, 7, and 14 post wound formation, and promote the proliferation of epidermal cells. Two proteins that were differentially expressed between the different groups, i.e., IGF-1 and EGFR, were further validated. Serum ELISA assays showed that serum EGFR in the HYSJD treatment group was significantly increased. KEGG pathway analysis suggested that the PI3K/AKT pathway involved in HYSJD promoting the proliferation of epidermal cells in chronic wounds in db/db mice. Experimental verification showed that HYSJD activated the PI3K/AKT signaling pathway in mouse wound skin. Conclusion: HYSJD promotes the proliferation of epidermal cells in chronic diabetic wounds by increasing EGFR expression in the wounds and activating the PI3K/AKT signaling pathway. Our study provides an experimental basis for the pharmacological mechanism of HYSJD.


  • Open Access

    Huiyang Shengji Extract Improve Chronic Nonhealing Cutaneous through the TGF-β1/Smad3 Signaling Pathway

    by Yan Lin, Xiujuan He, Xinran Xie, Qingwu Liu, Jia Chen, Ping Li

    Chronic nonhealing cutaneous wounds are a thorny problem in the field of surgery because of their prolonged and unhealed characteristics. Huiyang Shengji extract (HSE) is an extract of traditional Chinese medicine prescription for treating chronic wounds. This study aims to investigate the regulation of M1 macrophages on fibroblast proliferation and secretion and the intervention mechanism of Huiyang Shengji extract. We found that the effects of HSFs stimulated with paracrine factors from M1 macrophages were as follows: the proliferation of HSFs was reduced, the expression of MKI-67 was downregulated, and the content and gene expression of the inflammation factors and fibroblast MMPs were increased, while the content and gene expression of TIMP-1 are decreased, the content of human fibroblasts secreting type I collagen (COL1A1) and type III collagen (COL3A1) was decreased, and the TGF-β1/Smad3 signaling pathway was inhibited. Interestingly, HSE inhibited these effects of M1 macrophages on human fibroblasts after the intervention, and the inhibitory effect was related to the concentration. In conclusion, M1 macrophages caused changes in HSFs and secretion, while HSE has a specific regulatory effect on the proliferation and secretion of fibroblasts caused by M1 macrophages.


  • Open Access

    Liangxue Jiedu Formula Improves Psoriasis and Dyslipidemia Comorbidity via PI3K/Akt/mTOR Pathway

    by Xinran Xie, Lei Zhang, Xue Li, Weihong Liu, Ping Wang, Yan Lin, Xuyang Han, Ping Li

    The pathological mechanism of psoriasis and dyslipidemia comorbidity is unclear, and there are few reports on therapy. By establishing an animal model of ApoE−/− mice induced by imiquimod (IMQ), we explored the effects of Liangxue Jiedu formula (LXJDF), a traditional Chinese herb medicine, on psoriasis and dyslipidemia comorbidity through PI3K/Akt/mTOR pathway. The experiment was divided into a control group, a model group, an LXJDF high-dose group, an LXJDF low-dose group, and a positive drug (atorvastatin) group. Each group of mice was given continuous oral administration once a day. After 3 weeks, the mice dorsal skins were smeared with 62.5 mg of 5% IMQ cream for five consecutive days and continued to be given the corresponding drugs. We observed the effects of LXJDF on skin lesion changes, PASI score, pathological characteristics, blood lipid levels (TC, TG, LDL, HDL, and oxLDL), liver pathology, inflammatory factors in the skin, and the protein expression of PI3K/Akt/mTOR pathway in both the skin and liver. The results showed that LXJDF could significantly improve the psoriasiform skin lesions of IMQ-induced ApoE−/− mice, including the reduction of PASI, thinning of epidermal thickness, inhibition of hyperkeratosis and parakeratosis, and inflammatory infiltration in the dermis, and reduce lipid accumulation in the epidermal. LXJDF could regulate blood lipid levels, reduce liver inflammation, and protect the liver. LXJDF could significantly decrease the gene expressions of inflammatory factors IL-17A, IL-23, IL-6, and TNF-α in the skin. LXJDF showed specific inhibition of PI3K, Akt, mTOR protein, and its phosphorylation expressions. In conclusion, LXJDF exerts an intervention effect on psoriasis and dyslipidemia comorbidity via PI3K/Akt/mTOR and its phosphorylation pathway.